In addition, the expression of psoriasis-related inflammatory response markers, including Keratin 16, S100A8, and S100A9 (Ebihara et al, 2015), was not reduced by anti-FGFR2IIIb treatment (Fig 5M–O). Here, S100A8 is linked to psoriasis.